Besifovir dipivoxil
- Generic Name
- Besifovir dipivoxil
- Drug Type
- Small Molecule
- Chemical Formula
- C22H34N5O8P
- CAS Number
- 441785-26-8
- Unique Ingredient Identifier
- S9I9P4J8IU
Overview
Besifovir dipivoxil is a small-molecule orally available inhibitor of the HBV polymerase. The HBV polymerase is the enzyme that catalyzes the production of new RNA from the existing strand of RNA. Besifovir dipivoxil is believed to inhibit viral proliferation by interrupting the replicating machinery of the virus.
Background
Besifovir dipivoxil is a small-molecule orally available inhibitor of the HBV polymerase. The HBV polymerase is the enzyme that catalyzes the production of new RNA from the existing strand of RNA. Besifovir dipivoxil is believed to inhibit viral proliferation by interrupting the replicating machinery of the virus.
Indication
Investigated for use/treatment in hepatitis (viral, B).
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.